Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
Article in Frontiers in Immunology (October 2023)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (October 2023)
Article in Atherosclerosis (June 2023)
Article in Journal of Proteomics (June 2023)